×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Silk Road Medical Stock Forecast, Price & News

$38.94
+2.55 (+7.01%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.88
$39.06
50-Day Range
$28.03
$40.13
52-Week Range
$27.21
$67.49
Volume
214,974 shs
Average Volume
351,218 shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00

Silk Road Medical Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.60 Rating Score
Upside/​Downside
28.4% Upside
$50.00 Price Target
Short Interest
Bearish
7.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$1.30 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.77) to ($1.36) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.09 out of 5 stars

Medical Sector

894th out of 1,429 stocks

Surgical & Medical Instruments Industry

95th out of 138 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive SILK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter.

Silk Road Medical logo

About Silk Road Medical (NASDAQ:SILK)

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

SILK Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SILK
Employees
352
Year Founded
N/A

Company Calendar

Last Earnings
5/04/2022
Today
7/02/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$50.00
High Stock Price Forecast
$66.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+28.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.6
Research Coverage
5 Analysts

Profitability

Net Income
$-49.81 million
Pretax Margin
-51.93%

Debt

Sales & Book Value

Annual Sales
$101.47 million
Book Value
$2.27 per share

Miscellaneous

Free Float
32,412,000
Market Cap
$1.37 billion
Optionable
Not Optionable
Beta
1.59














Silk Road Medical Frequently Asked Questions

Should I buy or sell Silk Road Medical stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical
or view top-rated stocks.

What is Silk Road Medical's stock price forecast for 2022?

5 brokers have issued 1 year price targets for Silk Road Medical's shares. Their SILK stock forecasts range from $33.00 to $66.00. On average, they expect Silk Road Medical's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 28.4% from the stock's current price.
View analysts' price targets for Silk Road Medical
or view top-rated stocks among Wall Street analysts.

How has Silk Road Medical's stock performed in 2022?

Silk Road Medical's stock was trading at $42.61 at the beginning of the year. Since then, SILK shares have decreased by 8.6% and is now trading at $38.94.
View the best growth stocks for 2022 here
.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Silk Road Medical
.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Wednesday, May, 4th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $0.07. The firm earned $28 million during the quarter, compared to the consensus estimate of $27.10 million. Silk Road Medical had a negative net margin of 51.93% and a negative trailing twelve-month return on equity of 67.38%. The business's revenue was up 39.7% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.31) EPS.
View Silk Road Medical's earnings history
.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical updated its FY 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $127.00 million-$132.00 million, compared to the consensus revenue estimate of $129.54 million.

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $38.94.

How much money does Silk Road Medical make?

Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.37 billion and generates $101.47 million in revenue each year. The company earns $-49.81 million in net income (profit) each year or ($1.61) on an earnings per share basis.

How many employees does Silk Road Medical have?

Silk Road Medical employs 352 workers across the globe.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for Silk Road Medical is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at [email protected], or via fax at 408-720-9013.

This page (NASDAQ:SILK) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.